Literature DB >> 8916636

Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse.

J D Killen1, S P Fortmann, H C Kraemer, A N Varady, L Davis, B Newman.   

Abstract

Signal detection methods were used to develop an algorithm useful in distinguishing those at risk for late relapse from those likely to maintain abstinence. Four subgroups with 24-month survival (nonrelapse) rates ranging from 79% to 33% were identified. Among participants whose depression symptoms decreased from baseline to the end of treatment, lower levels of nicotine dependence were associated with less relapse at the 24-month follow-up (odds ratio = 2.77; 95% confidence interval: 1.36-5.62). Among participants whose depression symptoms increased from baseline to the end of treatment, greater weight gain was associated with less relapse at follow-up (odds ratio = 2.90; 95% confidence interval: 1.41-5.96). This study suggested that it may become possible to use both baseline and treatment information to "titrate" interventions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916636     DOI: 10.1037//0022-006x.64.5.1060

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  27 in total

Review 1.  Do changes in mood and concerns about weight relate to smoking relapse in the postpartum period?

Authors:  M D Levine; M D Marcus
Journal:  Arch Womens Ment Health       Date:  2004-04-16       Impact factor: 3.633

2.  Exploring refinements in targeted behavioral medicine intervention to advance public health.

Authors:  Abby C King; David F Ahn; Audie A Atienza; Helena C Kraemer
Journal:  Ann Behav Med       Date:  2008-06-21

3.  Life adversity is associated with smoking relapse after a quit attempt.

Authors:  Andrine Lemieux; Leif Olson; Motohiro Nakajima; Lauren Schulberg; Mustafa al'Absi
Journal:  Addict Behav       Date:  2016-04-06       Impact factor: 3.913

4.  Predictors of quitting among African American light smokers enrolled in a randomized, placebo-controlled trial.

Authors:  Nicole L Nollen; Matthew S Mayo; Lisa Sanderson Cox; Kolawole S Okuyemi; Won S Choi; Harsohena Kaur; Jasjit S Ahluwalia
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

Review 5.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses.

Authors:  Yong Cui; Jason D Robinson; Jeffrey M Engelmann; Cho Y Lam; Jennifer A Minnix; Maher Karam-Hage; David W Wetter; John A Dani; Thomas R Kosten; Paul M Cinciripini
Journal:  Psychol Addict Behav       Date:  2015-01-26

7.  Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study.

Authors:  Yong Cui; Jeffrey M Engelmann; Jonathan Xian; Jennifer A Minnix; Cho Y Lam; Maher Karam-Hage; Paul M Cinciripini; Jason D Robinson
Journal:  Int J Psychophysiol       Date:  2017-12-06       Impact factor: 2.997

8.  Early life adversity influences stress response association with smoking relapse.

Authors:  Mustafa al'Absi; Andrine Lemieux; Ruth Westra; Sharon Allen
Journal:  Psychopharmacology (Berl)       Date:  2017-09-05       Impact factor: 4.530

9.  Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.

Authors:  Robert A Schnoll; Elisa Martinez; Kristina L Tatum; Marcella Glass; Albert Bernath; Daron Ferris; Patrick Reynolds
Journal:  Addict Behav       Date:  2010-09-24       Impact factor: 3.913

10.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.